Literature DB >> 15834638

Exon 15 BRAF mutations are uncommon in canine oral malignant melanomas.

Suzanne Shelly1, May B Chien, Becky Yip, Michael S Kent, Alain P Theon, Jennifer L McCallan, Cheryl A London.   

Abstract

An activating mutation in codon 599 of BRAF has been identified in approximately 60% of human cutaneous nevi and melanomas, but not melanomas of mucosal origin. The purpose of this study was to determine if BRAF mutations occur in canine oral malignant melanomas. The canine BRAF gene was first cloned from normal canine testicular cDNA, and a novel previously unreported splice variant involving exon 5 was identified during this process. To screen canine melanoma samples for BRAF mutation in codon 599, cDNA and genomic DNA were isolated from canine malignant melanoma cell lines and primary tumor samples respectively, all from cases seen at the Veterinary Medical Teaching Hospital at the University of California, Davis. Polymerase chain reaction (PCR) was performed for exon 15 using primers based at the 5' end of exon 15 and the 5' end of intron 15 and the resultant products were directly sequenced. No mutations in codon 599 or exon 15 were identified in any of the 17 samples evaluated. However, all of the melanoma cell lines expressed BRAF and demonstrated high levels of basal ERK phosphorylation suggesting that dysregulation of this pathway is present. Therefore, similar to the case with human mucosal melanomas, canine oral malignant melanomas do not possess codon 599 BRAF mutations commonly identified in human cutaneous melanomas. This finding supports the notion that melanomas arising from non-sun-exposed sites exhibit distinct mechanisms of molecular transformation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15834638     DOI: 10.1007/s00335-004-2441-x

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  32 in total

1.  Radiotherapy of oral malignant melanomas in dogs.

Authors:  L Blackwood; J M Dobson
Journal:  J Am Vet Med Assoc       Date:  1996-07-01       Impact factor: 1.936

2.  Prognostic criteria for dogs with oral melanoma.

Authors:  H J Harvey; E G MacEwen; D Braun; A K Patnaik; S J Withrow; S Jongeward
Journal:  J Am Vet Med Assoc       Date:  1981-03-15       Impact factor: 1.936

Review 3.  Discovery of a novel Raf kinase inhibitor.

Authors:  J F Lyons; S Wilhelm; B Hibner; G Bollag
Journal:  Endocr Relat Cancer       Date:  2001-09       Impact factor: 5.678

4.  Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation.

Authors:  Kapaettu Satyamoorthy; Gang Li; Michelle R Gerrero; Marcia S Brose; Patricia Volpe; Barbara L Weber; Patricia Van Belle; David E Elder; Meenhard Herlyn
Journal:  Cancer Res       Date:  2003-02-15       Impact factor: 12.701

Review 5.  Raf proteins and cancer: B-Raf is identified as a mutational target.

Authors:  Kathryn E Mercer; Catrin A Pritchard
Journal:  Biochim Biophys Acta       Date:  2003-06-05

6.  Oncogenic B-Raf mutations: crystal clear at last.

Authors:  Amardeep S Dhillon; Walter Kolch
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

Review 7.  Mechanisms of regulating the Raf kinase family.

Authors:  Huira Chong; Haris G Vikis; Kun-Liang Guan
Journal:  Cell Signal       Date:  2003-05       Impact factor: 4.315

8.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

9.  Lack of BRAF mutations in uveal melanoma.

Authors:  Donata Rimoldi; Suzanne Salvi; Danielle Liénard; Ferdy J Lejeune; Daniel Speiser; Leonidas Zografos; Jean-Charles Cerottini
Journal:  Cancer Res       Date:  2003-09-15       Impact factor: 12.701

10.  Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites.

Authors:  Yoram Cohen; Eli Rosenbaum; Shahnaz Begum; David Goldenberg; Clemens Esche; Ofer Lavie; David Sidransky; William H Westra
Journal:  Clin Cancer Res       Date:  2004-05-15       Impact factor: 12.531

View more
  16 in total

1.  Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma.

Authors:  Karl C Bruckman; Frank Schönleben; Wanglong Qiu; Victoria L Woo; Gloria H Su
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-09-01

2.  6-Bromoindirubin-3'oxime (BIO) decreases proliferation and migration of canine melanoma cell lines.

Authors:  Esther Chon; Brandi Flanagan; Lucas Campos de Sá Rodrigues; Caroline Piskun; Timothy J Stein
Journal:  Vet J       Date:  2014-07-31       Impact factor: 2.688

3.  Homologous Mutation to Human BRAF V600E Is Common in Naturally Occurring Canine Bladder Cancer--Evidence for a Relevant Model System and Urine-Based Diagnostic Test.

Authors:  Brennan Decker; Heidi G Parker; Deepika Dhawan; Erika M Kwon; Eric Karlins; Brian W Davis; José A Ramos-Vara; Patty L Bonney; Elizabeth A McNiel; Deborah W Knapp; Elaine A Ostrander
Journal:  Mol Cancer Res       Date:  2015-03-12       Impact factor: 5.852

4.  Expression of leptin and iNOS in oral melanomas in dogs.

Authors:  V R Greene; H Wilson; C Pfent; J Roethele; J Carwile; Y Qin; E Grimm; J A Ellerhorst
Journal:  J Vet Intern Med       Date:  2013-08-26       Impact factor: 3.333

5.  Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study.

Authors:  Cheryl A London; Luis Feo Bernabe; Sandra Barnard; William C Kisseberth; Antonella Borgatti; Mike Henson; Heather Wilson; Kiersten Jensen; Daisuke Ito; Jaime F Modiano; Misty D Bear; Michael L Pennell; Jean-Richard Saint-Martin; Dilara McCauley; Michael Kauffman; Sharon Shacham
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

6.  Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.

Authors:  R Mark Simpson; Boris C Bastian; Helen T Michael; Joshua D Webster; Manju L Prasad; Catherine M Conway; Victor M Prieto; Joy M Gary; Michael H Goldschmidt; D Glen Esplin; Rebecca C Smedley; Adriano Piris; Donald J Meuten; Matti Kiupel; Chyi-Chia R Lee; Jerrold M Ward; Jennifer E Dwyer; Barbara J Davis; Miriam R Anver; Alfredo A Molinolo; Shelley B Hoover; Jaime Rodriguez-Canales; Stephen M Hewitt
Journal:  Pigment Cell Melanoma Res       Date:  2013-11-21       Impact factor: 4.693

7.  IQGAP1 is an oncogenic target in canine melanoma.

Authors:  Becky H Lee; Poornima H Neela; Michael S Kent; Ashley M Zehnder
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

8.  BRAF Mutations in Canine Cancers.

Authors:  Hiroyuki Mochizuki; Katherine Kennedy; Susan G Shapiro; Matthew Breen
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

9.  Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma.

Authors:  Bih-Rong Wei; Helen T Michael; Charles H C Halsey; Cody J Peer; Amit Adhikari; Jennifer E Dwyer; Shelley B Hoover; Rajaa El Meskini; Serguei Kozlov; Zoe Weaver Ohler; William D Figg; Glenn Merlino; R Mark Simpson
Journal:  Pigment Cell Melanoma Res       Date:  2016-09-22       Impact factor: 4.693

Review 10.  Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas.

Authors:  Belen Hernandez; Hibret A Adissu; Bih-Rong Wei; Helen T Michael; Glenn Merlino; R Mark Simpson
Journal:  Int J Mol Sci       Date:  2018-01-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.